Browse > Article
http://dx.doi.org/10.3343/alm.2018.38.6.591

Association of FOXP3 Single Nucleotide Polymorphisms With Clinical Outcomes After Allogenic Hematopoietic Stem Cell Transplantation  

Nam, Minjeong (Department of Laboratory Medicine, Seoul National University College of Medicine)
Shin, Sue (Department of Laboratory Medicine, Seoul National University College of Medicine)
Park, Kyoung Un (Department of Laboratory Medicine, Seoul National University College of Medicine)
Kim, Inho (Department of Internal Medicine, Seoul National University College of Medicine)
Yoon, Sung-Soo (Department of Internal Medicine, Seoul National University College of Medicine)
Kwon, Tack-Kyun (Department of Otorhinolaryngology, Seoul National University College of Medicine)
Song, Eun Young (Department of Laboratory Medicine, Seoul National University College of Medicine)
Publication Information
Annals of Laboratory Medicine / v.38, no.6, 2018 , pp. 591-598 More about this Journal
Abstract
Background: Forkhead box P3 (FOXP3) is an important marker of regulatory T cells. FOXP3 polymorphisms are associated with autoimmune diseases, cancers, and allograft outcomes. We examined whether single nucleotide polymorphisms (SNPs) at the FOXP3 locus are associated with clinical outcomes after allogenic hematopoietic stem cell transplantation (HSCT). Methods: Five FOXP3 SNPs (rs5902434, rs3761549, rs3761548, rs2232365, and rs2280883) were analyzed by PCR-sequencing of 172 DNA samples from allogenic HSCT patients. We examined the relationship between each SNP and the occurrence of graft-versus-host disease (GVHD), post-HSCT infection, relapse, and patient survival. Results: Patients with acute GVHD (grades II-IV) showed higher frequencies of the rs3761549 T/T genotype, rs5902434 ATT/ATT genotype, and rs2232365 G/G genotype than did patients without acute GVHD (P =0.017, odds ratio [OR]=5.3; P =0.031, OR=2.4; and P =0.023, OR=2.6, respectively). Multivariate analysis showed that the TT genotype of rs3761549 was an independent risk factor for occurrence of acute GVHD (P =0.032, hazard ratio=5.6). In contrast, the genotype frequencies of rs3761549 T/T, rs5902434 ATT/ATT, and rs2232365 G/G were lower in patients with post-HSCT infection than in patients without infection (P =0.026, P =0.046, and P =0.031, respectively). Conclusions: rs3761549, rs5902434, and rs2232365 are associated with an increased risk of acute GVHD and decreased risk of post-HSCT infection.
Keywords
Allogenic hematopoietic stem cell transplantation; FOXP3; Graft-versus-host disease; Infection; Polymorphism;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Gratama JW, van Esser JW, Lamers CH, Tournay C, Lowenberg B, Bolhuis RL, et al. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001;98:1358-64.   DOI
2 van Esser JW, van der Holt B, Meijer E, Niesters HG, Trenschel R, Thijsen SF, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogenic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT. Blood 2001;98:972-8.   DOI
3 Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775-87.   DOI
4 von Herrath MG and Harrison LC. Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 2003;3:223-32.   DOI
5 Le NT and Chao N. Regulating regulatory T cells. Bone Marrow Transplant 2007;39:1-9.   DOI
6 Elbadry MI, Noreldin AKA, Hassanein HA. After moving of regulatory T-cell therapy to the clinic: will we need a new Tregs source? Hematol Transfus Int J 2017;5:00117.
7 Singer BD, King LS, D'Alessio FR. Regulatory T cells as immunotherapy. Front Immunol 2014;5:1-10.
8 Curiel TJ. Regulatory T-cell development: is Foxp3 the decider? Nat Med 2007;13:250-3.   DOI
9 Oda JM, Hiraata BK, Guembarovski RL, Watanabe MA. Genetic polymorphism in FOXP3 gene: imbalance in regulatory T-cell role and development of human diseases. J Genet 2013;92:163-71.   DOI
10 Marques CR, Costa RS, Costa GNO, da Silva TM, Teixeira TO, de Andrade EMM, et al. Genetic and epigenetic studies of FOXP3 in asthma and allergy. Asthma Res Pract 2015;1:10.   DOI
11 Chen X, Gan T, Liao Z, Chen S, Xiao J. Foxp3 (-/ATT) polymorphism contributes to the susceptibility of preeclampsia. PLoS One 2013;8:e59696.   DOI
12 Lin YC, Lee JH, Wu AS, Tsai CY, Yu HH, Wang LC, et al. Association of single-nucleotide polymorphisms in FOXP3 gene with systemic lupus erythematosus susceptibility: a case-control study. Lupus 2011;20:137-43.   DOI
13 Bossowski A, Borysewicz-Sanczyk H, Wawrusiewicz-Kurylonek N, Zasim A, Szalecki M, Wikiera B, et al. Analysis of chosen polymorphisms in FoxP3 gene in children and adolescents with autoimmune thyroid diseases. Autoimmunity 2014;47:395-400.   DOI
14 Fazelzadeh Haghighi M, Ali Ghayumi M, Behzadnia F, Erfani N. Investigation of FOXP3 genetic variations at positions -2383 C/T and IVS9+459 T/C in southern Iranian patients with lung carcinoma. Iran J Basic Med Sci 2015;18:465-71.
15 Jiang LL and Ruan LW. Association between FOXP3 promoter polymorphisms and cancer risk: a meta-analysis. Oncol Lett 2014;8:2795-9.   DOI
16 Mojtahedi Z, Erfani N, Haghshenas MR, Hosseini SV, Ghaderi A. Association of FoxP3/Scurfin germline polymorphism (C-2383T/rs3761549) with colorectal cancer. Ann Colorectal Res 2013;1:12-6.   DOI
17 Qiu XY, Jiao Z, Zhang M, Chen JP, Shi XJ, Zhong MK. Genetic association of FOXP3 gene polymorphisms with allograft rejection in renal transplant patients. Nephrology (Carlton) 2012;17:423-30.   DOI
18 Misra MK, Mishra A, Pandey SK, Kapoor R, Sharma RK, Agrawal S. Association of functional genetic variants of transcription factor Forkhead Box P3 and Nuclear Factor-${\kappa}B$ with end-stage renal disease and renal allograft outcome. Gene 2016;581:57-65.   DOI
19 Engela AU, Boer K, Roodnat JI, Peeters AM, Eilers PH, Kal-van Gestel JA, et al. Genetic variants of FOXP3 influence graft survival in kidney transplant patients. Hum Immunol 2013;74:751-7.   DOI
20 Piao Z, Kim HJ, Choi JY, Hong CR, Lee JW, Kang HJ, et al. Effect of FOXP3 polymorphism on the clinical outcomes after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia patients. Int Immunopharmacol 2016;31:132-9.   DOI
21 Gratwohl A. The EBMT risk score. Bone Marrow Transplant 2012;47: 749-56.   DOI
22 Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825-8.
23 Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11:945-56.   DOI
24 Barbosa CP, Teles JS, Lerner TG, Peluso C, Mafra FA, Vilarino FL, et al. Genetic association study of polymorphisms FOXP3 and FCRL3 in women with endometriosis. Fertil Steril 2012;97:1124-8.   DOI
25 Andre GM, Barbosa CP, Teles JS, Vilarino FL, Christofolini DM, Bianco B, et al. Analysis of FOXP3 polymorphisms in infertile women with and without endometriosis. Fertil Steril 2011;95:2223-7.   DOI
26 Beres AJ and Drobyski WR. The role of regulatory T cells in the biology of graft versus host disease. Front Immunol 2013;4:163.
27 Wu Z, You Z, Zhang C, Li Z, Su X, Zhang X, et al. Association between functional polymorphisms of Foxp3 gene and the occurrence of unexplained recurrent spontaneous abortion in a Chinese Han population. Clin Dev Immunol 2012;2012:896458.
28 Gao L, Li K, Li F, Li H, Liu L, Wang L, et al. Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients. J Dermatol Sci 2010; 57:51-6.   DOI
29 Song EY, Park MH, Kang SJ, Park HJ, Kim BC, Tokunaga K, et al. HLA class II allele and haplotype frequencies in Koreans based on 107 families. Tissue Antigens 2002;59:475-86.   DOI
30 Arnaout K, Patel N, Jain M, El-Amm J, Amro F, Tabbara IA, et al. Complications of allogeneic hematopoietic stem cell transplantation. Cancer Invest 2014;32:349-62.   DOI
31 Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 2007;7:875-88.   DOI
32 Manuel O, Wojtowicz A, Bibert S, Mueller NJ, van Delden C, Hirsch HH, et al. Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation. J Infect Dis 2015;211:906-14.   DOI
33 Chekmenev DS, Haid C, Kel AE. P-Match: transcription factor binding site search by combining pattern and weight matrices. Nucleic Acids Res 2005;1:432-7.
34 Chou C, Pinto AK, Curtis JD, Persaud SP, Cella M, Lin CC, et al. c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells. Nat Immunol 2014;15:884-93.   DOI
35 Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S, et al. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 2005;106:2903-11.   DOI
36 Mittrucker HW, Kaufmann SH. Mini-review: regulatory T cells and infection: suppression revisited. Eur J Immunol 2004;34:306-12.   DOI
37 Mills KH. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 2004;4:841-55.   DOI
38 Belkaid Y and Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005;6:353-60.
39 Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004;78: 2454-9.   DOI
40 Fernandez-Ruiz M, Corrales I, Arias M, Campistol JM, Gimenez E, Crespo J, et al. Association between individual and combined SNPs in genes related to innate immunity and incidence of CMV infection in seropositive kidney transplant recipients. Am J Transplant 2015;15:1323-35.   DOI